Trial Profile
The Long Term Effects of Alfuzosin (Xatral XL) in LUTS/BPH Patients: Evaluation of Symptom-Specific Goal Achievement According to Symptom Improvement, Bladder Outlet Obstruction Grade and Bladder Contractility.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2023
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- 11 Feb 2009 New trial record